Hospitals | April 21, 2026
Aster CMI Hospital launches Karnataka’s first pediatric liver ICU ‘PEARL’
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
Full approval will depend on verification of clinical benefit in a confirmatory trial
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
Poly Medicure has reported total income of Rs. 477.82 crore during the period ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
